Our previous study found that traditional Chinese medicine could improve the tumor microenvironment of patients to treat liver cancer and speculated that the immune checkpoints CTLA-4, LAG-3, and BIRC5 are the key targets for activating immune cells to treat liver cancer (Mo et al., 2020). Here, CTLA4 is linked to neoplasm.